ORCHPHARMA Q1 FY27 results at a glance
ORCHID PHARMA LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹304 cr |
|---|
| Revenue YoY | +15.6% |
|---|
| Operating profit | ₹3.05 cr |
|---|
| Operating margin | 1.0% |
|---|
| Net profit | ₹3.22 cr |
|---|
| Net profit YoY | +156.6% |
|---|
| Net profit QoQ | -86.4% |
|---|
| Net margin | 1.1% |
|---|
| Basic EPS | ₹0.54 |
|---|
| TTM revenue | ₹943 cr |
|---|
| TTM net profit | ₹8.67 cr |
|---|
| TTM net margin | 0.9% |
|---|
ORCHPHARMA Q1 FY27 results: what the numbers say
ORCHID PHARMA LIMITED (ORCHPHARMA) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹304 cr and a net profit of ₹3.22 cr, translating into earnings per share of ₹0.54.
Compared with the same quarter a year earlier, revenue grew by +15.6% and net profit grew sharply by +156.6%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹3.05 cr, an operating margin of 1.0% versus -6.1% a year ago — a gain of 7.1 percentage points.
ORCHPHARMA quarter-wise results table
Net profit
₹3.22 cr
+156.6% YoY
Operating profit
₹3.05 cr
+118.9% YoY
ORCHID PHARMA LIMITED (ORCHPHARMA) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹304 cr | ₹3.05 cr | ₹3.22 cr | 1.0% | 1.1% | ₹0.54 | +156.6% | -86.4% |
| Q4 FY262026-03-31 | ₹238 cr | ₹56.5 cr | ₹23.78 cr | 23.8% | 10.0% | ₹4.69 | — | +288.5% |
| Q3 FY262025-12-31 | ₹207 cr | ₹30.96 cr | -₹12.61 cr | 14.9% | -6.1% | ₹-2.49 | — | -120.4% |
| Q2 FY262025-09-30 | ₹194 cr | -₹10.38 cr | -₹5.72 cr | -5.4% | -3.0% | ₹-1.13 | — | -0.6% |
| Q1 FY262025-06-30 | ₹263 cr | -₹16.18 cr | -₹5.69 cr | -6.1% | -2.2% | ₹-0.95 | — | — |
| TTM (last 4 quarters) | ₹943 cr | ₹80.14 cr | ₹8.67 cr | 8.5% | 0.9% | ₹1.61 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
ORCHPHARMA quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
ORCHID PHARMA LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹304 cr | ₹238 cr | ₹207 cr | ₹194 cr | ₹263 cr |
|---|
| Total expenses | ₹301 cr | ₹181 cr | ₹176 cr | ₹204 cr | ₹279 cr |
|---|
| Gross profit | ₹99.87 cr | ₹86.25 cr | ₹64.12 cr | ₹61.02 cr | ₹79.79 cr |
|---|
| Operating profit (EBIT) | ₹3.05 cr | ₹56.5 cr | ₹30.96 cr | -₹10.38 cr | -₹16.18 cr |
|---|
| Operating margin | 1.0% | 23.8% | 14.9% | -5.4% | -6.1% |
|---|
| Interest cost | ₹2.23 cr | ₹3.09 cr | ₹3.18 cr | ₹3.73 cr | ₹2.28 cr |
|---|
| Profit before tax | ₹2.65 cr | ₹22.79 cr | -₹12.15 cr | -₹3.33 cr | -₹6.89 cr |
|---|
| Tax expense | ₹0.07 cr | ₹0 cr | ₹0 cr | ₹0 cr | ₹0 cr |
|---|
| Effective tax rate | 2.7% | 0.0% | 0.0% | 0.0% | 0.0% |
|---|
| Net profit (PAT) | ₹3.22 cr | ₹23.78 cr | -₹12.61 cr | -₹5.72 cr | -₹5.69 cr |
|---|
| Net profit margin | 1.1% | 10.0% | -6.1% | -3.0% | -2.2% |
|---|
| Basic EPS | ₹0.54 | ₹4.69 | ₹-2.49 | ₹-1.13 | ₹-0.95 |
|---|
| Diluted EPS | ₹0.54 | ₹4.69 | ₹-2.49 | ₹-1.13 | ₹-0.95 |
|---|
ORCHPHARMA results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +15.6% | — | — | — | — |
|---|
| Revenue QoQ | +28.0% | +14.6% | +7.1% | -26.5% | — |
|---|
| Operating profit YoY | +118.9% | — | — | — | — |
|---|
| Operating profit QoQ | -94.6% | +82.5% | +398.4% | +35.9% | — |
|---|
| Net profit YoY | +156.6% | — | — | — | — |
|---|
| Net profit QoQ | -86.4% | +288.5% | -120.4% | -0.6% | — |
|---|
| EPS YoY | +156.8% | — | — | — | — |
|---|
| EPS QoQ | -88.5% | +288.4% | -120.4% | -18.9% | — |
|---|
ORCHPHARMA annual results history
Full-year performance for ORCHID PHARMA LIMITED, useful for reading each quarter in context.
ORCHID PHARMA LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹1,217 cr | ₹1,389 cr | ₹819 cr | ₹666 cr |
|---|
| Total expenses | ₹1,176 cr | ₹1,264 cr | ₹741 cr | ₹636 cr |
|---|
| Gross profit | ₹358 cr | ₹475 cr | ₹321 cr | ₹269 cr |
|---|
| Operating profit (EBIT) | ₹40.76 cr | ₹125 cr | ₹78.47 cr | ₹29.67 cr |
|---|
| Operating margin | 3.3% | 9.0% | 9.6% | 4.5% |
|---|
| Interest cost | ₹8.98 cr | ₹12.79 cr | ₹16.35 cr | ₹32.23 cr |
|---|
| Profit before tax | ₹10.43 cr | ₹122 cr | ₹91.95 cr | ₹55.25 cr |
|---|
| Tax expense | -₹0.19 cr | -₹9.64 cr | -₹3.12 cr | ₹0 cr |
|---|
| Effective tax rate | -1.8% | -7.9% | -3.4% | 0.0% |
|---|
| Net profit (PAT) | ₹9.96 cr | ₹135 cr | ₹92.17 cr | ₹46.32 cr |
|---|
| Net profit margin | 0.8% | 9.7% | 11.3% | 7.0% |
|---|
| Basic EPS | ₹1.66 | ₹22.55 | ₹19.06 | ₹11.35 |
|---|
| Diluted EPS | ₹1.66 | ₹22.55 | ₹19.06 | ₹11.35 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹304 cr against ₹263 cr in Q1 FY26, and ₹238 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +28.0%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹301 cr, or 99.0% of revenue, with operating profit grew +118.9% year on year.
Margins, tax and profitability
Net profit of ₹3.22 cr works out to a net margin of 1.1% compared with -2.2% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, ORCHID PHARMA LIMITED reported profit before tax of ₹2.65 cr, a tax charge of ₹0.07 cr (effective rate 2.7%), interest cost of ₹2.23 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹23.78 cr in Q4 FY26 to ₹3.22 cr in Q1 FY27, a change of -86.4%.
Trailing twelve months and annual context
Across the trailing four quarters ORCHID PHARMA LIMITED has generated revenue of ₹943 cr and net profit of ₹8.67 cr, a trailing net margin of 0.9%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹1,217 cr with net profit of ₹9.96 cr and EPS of ₹1.66, versus the prior year where revenue declined -12.4% and profit declined -92.6%.
What to watch in the next ORCHPHARMA quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
ORCHID PHARMA LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
ORCHPHARMA results coverage
No results report published for ORCHPHARMA yet — our desk covers each quarter within minutes of the filing.
ORCHPHARMA quarterly results FAQs
What were ORCHID PHARMA LIMITED (ORCHPHARMA) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), ORCHID PHARMA LIMITED reported revenue of ₹304 cr and net profit of ₹3.22 cr, a change of +156.6% year on year on +15.6% revenue growth. EPS stood at ₹0.54.
What is ORCHPHARMA profit margin in Q1 FY27?
ORCHID PHARMA LIMITED posted a net profit margin of 1.1% and an operating margin of 1.0% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹943 cr and net profit ₹8.67 cr.
Did ORCHPHARMA results beat the previous quarter?
ORCHID PHARMA LIMITED net profit changed -86.4% quarter on quarter, from ₹23.78 cr in Q4 FY26 to ₹3.22 cr in Q1 FY27.
When are ORCHID PHARMA LIMITED (ORCHPHARMA) quarterly results?
ORCHID PHARMA LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see ORCHPHARMA latest quarterly results?
Results coverage for ORCHPHARMA will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the ORCHPHARMA stock page.
What is ORCHID PHARMA LIMITED annual revenue and profit?
For FY26, ORCHID PHARMA LIMITED reported full-year revenue of ₹1,217 cr and net profit of ₹9.96 cr, with EPS of ₹1.66.
How many quarterly results has ORCHPHARMA declared recently?
Past results dates for ORCHPHARMA will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
